In a matter before the Hague District Court, CRA provided expert reports regarding the damages sustained by a generic entrant from the wrongful enforcement of an injunction preventing generic entry. In estimating the damages suffered, CRA analyzed and addressed questions regarding additional generic entry and how the introduction of additional products would have impacted sales of the generic. CRA analyzed trends in other European Union countries where there was no injunction against the generic to accurately estimate the sales that would have occurred and the lost profits suffered by the generic
Richard Bergin joins CRA's Finance Practice as Vice President
CRA is pleased to announce that Richard Bergin has joined the company’s Finance Practice as a vice president. “We are very pleased to welcome Richard to CRA,”...